2016 annual financial data
Inhibikase Therapeutics 2016 Operating margin
Inhibikase Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -63.4%.
Operating income was -613,288 USD and net income was -628,737 USD.
Operating cash flow was -29,573 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 967,386 USD
- Operating income
- -613,288 USD
- Net income
- -628,737 USD
- Operating cash flow
- -29,573 USD